Conformis up on U.S. FDA clearance of hip implant

ConforMIS

14/09/2022 11:04

** Shares of medical device maker Conformis Inc  CFMS.O 
rise 4.9% to $0.28 before the bell
    ** Co says it received clearance from FDA for its hip
implant, Actera  urn:newsml:reuters.com:*:nGNXc8FQs3
    ** CFMS will launch Actera in select U.S. markets in next
few months
    ** Up to Tuesday's close, stock had fallen ~65% YTD 

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))